The Australian tea tree oil industry is facing significant uncertainty due to a proposed regulatory change by the European Union. The European Chemicals Agency (ECHA) is considering a proposal to classify the essential oil as a Category 1B reproductive toxicant, citing potential hazards to fertility and fetal development.
If adopted, this classification under the EU's Classification, Labelling and Packaging (CLP) Regulation would mandate stringent hazard warnings on products containing tea tree oil sold in the EU. Industry representatives, including the Australian Tea Tree Industry Association (ATTIA), warn this could devastate the export market, valued at approximately $40 million annually, by damaging consumer confidence and increasing compliance costs.
The proposal, which was submitted by the German Federal Institute for Occupational Safety and Health (BAuA), is currently under scientific review. The Australian industry is actively contesting the classification, arguing that the proposed hazard assessment is based on high-dose, undiluted exposure not representative of typical consumer use in cosmetics and personal care products.
A final decision by the EU authorities is pending. The outcome will determine whether Australian producers must navigate a major new regulatory barrier in one of their key international markets.
